In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
about
Role of lipooligosaccharide in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant ratsMonoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraoseStructural and immunochemical characterization of a Neisseria gonorrhoeae epitope defined by a monoclonal antibody 2C7; the antibody recognizes a conserved epitope on specific lipo-oligosaccharides in spite of the presence of human carbohydrate epitRegulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactateExperimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkCResistance of Neisseria gonorrhoeae to neutrophils.Speciation of Campylobacter coli, C. jejuni, C. helveticus, C. lari, C. sputorum, and C. upsaliensis by matrix-assisted laser desorption ionization-time of flight mass spectrometry.Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.Lipid a is more than acyl chainsMucosal immunity in the genital tract: prospects for vaccines against sexually transmitted diseases--a review.Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophilsSequence-based predictions of lipooligosaccharide diversity in the Neisseriaceae and their implication in pathogenicity.Analysis of lipooligosaccharide biosynthesis in the Neisseriaceae.Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in GonococciThe Neisseria lipooligosaccharide-specific alpha-2,3-sialyltransferase is a surface-exposed outer membrane protein.Incorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.Mucosal infection with Neisseria gonorrhoeae. Bacterial adaptation and mucosal defensesStrategies for mimicking Neisserial saccharide epitopes as vaccines.The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membraneVaccines for bacterial sexually transmitted infections: a realistic goal?Neisseria gonorrhoeae utilizes and enhances the biosynthesis of the asialoglycoprotein receptor expressed on the surface of the hepatic HepG2 cell line.A lipooligosaccharide-binding site on HepG2 cells similar to the gonococcal opacity-associated surface protein OpaPhenotypic modulation of gonococcal lipooligosaccharide in acidic and alkaline culture.Gonococcal infection in a nonhuman host is determined by human complement C1q.Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeaeExpression of sialyltransferase is not required for interaction of Neisseria gonorrhoeae with human epithelial cells and human neutrophilsExpression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status.Interaction of pathogenic neisseriae with nonphagocytic cells.Pelvic inflammatory disease isolates of Neisseria gonorrhoeae are distinguished by C1q-dependent virulence for newborn rats and by the sac-4 regionA proposed role for the lutropin receptor in contact-inducible gonococcal invasion of Hec1B cellsSialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraoseSelection of Opa+ Neisseria gonorrhoeae by limited availability of normal human serumGenetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation.Antigenic variation in Neisseria gonorrhoeae: production of multiple lipooligosaccharides.Gonococci in vivo: Host CMP-NANA, sialylated lipopolysaccharide and serum resistanceSialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humansAnalysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae.Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.
P2860
Q24633533-94267A62-1640-43C2-8D4F-BDAC27D636E3Q28368192-0C67CD76-CD3E-41F6-AD55-465A2B74E165Q28377527-BB80BF3A-6E25-4998-81C0-C16C38A48429Q28379258-4650649B-AB4B-46B4-B581-EE8CA6E15DCDQ28743428-7007A859-3C5D-4C81-B272-1CBEAEECCB16Q30431442-0DDE2B4C-CD8D-4BBD-873C-4519F7B3B533Q33224570-29CA8E7F-924C-4830-925D-3CBBE1970CC1Q33594645-ED825320-6377-48CB-88FE-541A6D644AEDQ33602966-F4D59E81-9A30-4B7B-9207-283976A8FD49Q33701334-B76016D6-EA0A-43E1-BAA0-323CC97DB77EQ33751449-99DA9B43-1110-4ADD-8AAA-038A634F102FQ33886334-7847BB07-6C59-46E3-BDDC-7BFF9EE87CA4Q33995459-0B8F0D04-E448-4DA1-950A-1CF4260B0AE6Q34044438-F8616C21-8C65-485B-A228-6B0E690AE54FQ34111593-FD80E9A3-ED84-4850-B178-66A1B43FE282Q34126624-1C9D97FB-7631-439F-9087-4A608B9567D4Q34129976-2A1665BB-6751-45DD-809B-575AD3DE24D4Q34219062-FEBD6E2F-D148-4A5B-B9F2-77FF9ABF1596Q34552298-DAEF9F63-D6C3-49C4-B8CE-947DACC564F8Q34985648-7EACA9CB-9EC0-4433-BA7A-C5E7BA43AC1AQ35115350-14136F51-00A0-4622-8016-91636B848D09Q35403872-8A8E83A5-FADC-4BE5-933C-695AD0380D61Q35416067-9C62FADE-32B9-4E41-A5DD-614F449EABF2Q35425363-2C2E1A5E-48E0-4011-899C-47CB9A6E4792Q35456120-BDF246B2-77D7-4AD5-8F2D-1BB2AAE0BE69Q35513855-9975D1E3-9687-4CA8-8392-6A965BD6D945Q35523935-472E24BB-415C-4795-B3A3-7AF6C5C80294Q35528790-B88F973B-0F0B-452D-880C-E328C524EBC0Q35535077-D6AD8807-879E-4E3D-ACC7-5D066B95B36DQ35548614-26D82DAC-3033-4329-8122-3E36C738A345Q35555121-64F75708-4514-453D-A569-27D5D67F8F61Q35557535-01066DB1-2111-43B8-BCEB-61F42E758083Q35567295-39FFF452-856C-49C2-A99E-E06AEC22139FQ35600195-C4782B93-C936-4082-96F3-231F425FA0D5Q35619681-DE0B0D1E-1E06-4193-B57A-98BDC40B02D1Q35649893-1BD07A46-0DFD-404D-A935-B178F77D0F23Q35689455-A8B8157C-7392-4005-A9BB-E3A80F5B77F5Q35779576-3D8CD638-37B6-4BA7-8A12-DC3B4C8C7B11Q35859218-84A56E2A-9AC2-4407-8FAF-ACB999E56736Q35920654-1F9DD67A-951D-40F7-A46B-C3C644FCB1BF
P2860
In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
In vitro and in vivo modificat ...... tope structure by sialylation.
@ast
In vitro and in vivo modificat ...... tope structure by sialylation.
@en
type
label
In vitro and in vivo modificat ...... tope structure by sialylation.
@ast
In vitro and in vivo modificat ...... tope structure by sialylation.
@en
prefLabel
In vitro and in vivo modificat ...... tope structure by sialylation.
@ast
In vitro and in vivo modificat ...... tope structure by sialylation.
@en
P2093
P2860
P356
P1476
In vitro and in vivo modificat ...... tope structure by sialylation.
@en
P2093
J M Griffiss
N J Parsons
R E Mandrell
P2860
P304
P356
10.1084/JEM.171.5.1649
P407
P577
1990-05-01T00:00:00Z